Showing results (2031-2040 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 19, 2008
Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapyFrédérique Penault-Llorca, Catherine Abrial, Inès Raoelfils, et al.
The Oncologist|January 16, 2009
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancerHerbert I Hurwitz, Jing Yi, William Ince, et al.
The Oncologist|January 16, 2009
Sorafenib for the treatment of unresectable hepatocellular carcinomaRobert C Kane, Ann T Farrell, Rajanikanth Madabushi, et al.
The Oncologist|January 16, 2009
Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesisTerry Gernsheimer
The Oncologist|January 16, 2009
Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?Marc Peeters, Tim Price, Jean-Luc Van Laethem
The Oncologist|January 31, 2009
Bisphosphonates in oncology: rising stars or fallen heroesTim Van den Wyngaert, Manon T Huizing, Eric Fossion, et al.
The Oncologist|May 28, 2004
The role of ErbB inhibitors in trastuzumab resistanceKathy D Miller
The Oncologist|September 24, 2005
Fertility-sparing options for patients with gynecologic malignanciesMario M Leitao, Dennis S Chi
The Oncologist|August 4, 2007
Presurgical chemotherapy in patients being considered for liver resectionNancy Kemeny
The Oncologist|February 14, 2007
New, expanded, and modified use of approved antineoplastic agents in ovarian cancerMaurie Markman
Pageof 571